SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-012239
Filing Date
2024-05-03
Accepted
2024-05-03 18:00:48
Documents
1
Period of Report
2024-05-01

Document Format Files

Seq Description Document Type Size
1 form4-05032024_060515.html 4  
1 form4-05032024_060515.xml 4 7974
  Complete submission text file 0001415889-24-012239.txt   9452
Mailing Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130
Business Address 12830 EL CAMINO REAL SUITE 400 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130
Business Address
Teehan Brendan (Reporting) CIK: 0001891900 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 24914813